Blueprint Medicines Corporation
NASDAQ:BPMC
86 (USD) • At close October 17, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||
| Nettowinst
| -506.984 | -557.517 | -644.085 | 313.882 | -347.694 | -236.642 | -148.119 | -72.495 | -52.769 | -40.285 | -20.912 |
| Afschrijvingen & Amortisatie
| 11.665 | 11.735 | 6.479 | 6.559 | 5.259 | 4.246 | 1.578 | 1.582 | 0.948 | 0.622 | 0.501 |
| Uitgestelde Inkomstenbelasting
| 23.201 | 0 | 1.361 | 0.466 | -4.949 | 0 | -0.32 | 0.301 | 0.445 | 0.1 | -0.004 |
| Aandelen Gebaseerde Vergoedingen
| 92.672 | 98.971 | 91.63 | 75.526 | 54.653 | 30.534 | 12.523 | 6.14 | 5.18 | 2.326 | 0.351 |
| Verandering in Werkkapitaal
| -41.128 | -53.769 | -23.68 | -15.618 | 9.725 | 31.24 | 14.441 | 39.886 | 14.411 | 1.752 | 1.013 |
| Vorderingen
| -7.654 | 1.572 | -18.143 | -6.387 | -0.599 | 0.198 | 3.577 | -0.163 | -3.414 | 0 | 0 |
| Voorraden
| -4.366 | -8.922 | -12.561 | -6.707 | 8.97 | 0 | 6.873 | 6.939 | -0.078 | 0 | 0 |
| Crediteuren
| 1.88 | -5.816 | 4.221 | -0.791 | 1.448 | -0.445 | 1.532 | 0.004 | 1.391 | -0.512 | 0.541 |
| Overig Werkkapitaal
| -30.988 | -40.603 | 2.803 | -1.733 | -0.094 | 31.685 | 2.459 | 33.106 | 16.512 | 2.264 | 0.472 |
| Overige Niet-Contante Posten
| -16.273 | -1.697 | 269.642 | 6.22 | 4.991 | -4.387 | 0.032 | 0.073 | 0.109 | 0.085 | 0.026 |
| Kasstroom uit Operationele Activiteiten
| -436.847 | -502.277 | -298.653 | 387.035 | -278.015 | -175.009 | -119.865 | -24.513 | -31.676 | -35.4 | -19.025 |
| Investeringsactiviteiten: | |||||||||||
| Investeringen in Materiële Vaste Activa
| -16.062 | -8.919 | -261.241 | -3.159 | -14.013 | -12.677 | -15.512 | -2.354 | -4.883 | -0.7 | -0.257 |
| Netto Overnames
| 0 | 0 | 258.152 | 431.09 | 2.453 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -766.363 | -489.705 | -655.449 | -969.437 | -738.387 | -801.236 | -360.835 | -264.467 | -1.196 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 1,056.465 | 349.373 | 690.83 | 538.347 | 735.934 | 652.825 | 304 | 48 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | -0.29 | -258.152 | -431.09 | -2.453 | -148.411 | -3.501 | 0.119 | -1.196 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 274.04 | -149.541 | -225.86 | -434.249 | -16.466 | -161.088 | -75.848 | -218.702 | -6.079 | -0.7 | -0.257 |
| Financieringsactiviteiten: | |||||||||||
| Schuldaflossingen
| -97.933 | -553.614 | 0 | 0 | 0 | -1.69 | -2.583 | -3.333 | -1.806 | -0.75 | -3 |
| Uitgifte van Gewone Aandelen
| 21.336 | 8.196 | 50.716 | 617.759 | 340.754 | 6.425 | 547.496 | 135.91 | 157.074 | 0.268 | 0.053 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 5.271 | 0.928 | 0.259 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 195.822 | 1,107.228 | 50.716 | 617.759 | 340.638 | -0.281 | -0.965 | 135.91 | -2.046 | 81.835 | 17.939 |
| Kasstroom uit Financieringsactiviteiten
| 119.225 | 561.81 | 50.716 | 617.759 | 340.638 | 4.454 | 543.948 | 132.577 | 153.222 | 81.353 | 17.992 |
| Overige Informatie: | |||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.202 | -0.207 | -0.888 | -0.345 | 0.018 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -48.423 | -90.215 | -474.685 | 570.2 | 46.175 | -331.643 | 348.235 | -110.638 | 115.467 | 45.253 | -1.29 |
| Kaspositie aan het Einde van de Periode
| 71.286 | 124.904 | 215.119 | 689.804 | 119.604 | 73.429 | 400.304 | 52.069 | 162.707 | 47.24 | 1.987 |